Gene edited immune therapy CPD

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

Info

You must login to watch this lecture.

x Mobile version: slides + audio only
-15s 00:00 / 19:53 +15s
Minimise video

Professor Waseem Qasim describes how immune cells are the ideal first applications of gene editing. Using a range of studies, Professor Qasim discusses using viral vectors, the UCART19 bridge, and future applications of the research. 

This lecture was filmed at the 'gene editing in medicine: breakthrough or thin end of the wedge?' meeting at the Royal Society of Medicine in London.

Date of lecture: 3rd February 2017

Length: 00:19:53

Tips about RSM Videos

  • This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
  • This video is linked to a CPD credit. Both RSM members and non-members must login before watching the video to be able to claim a CPD credit.
  • Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
  • Click on the Chapters tab to view different parts of the video.

Error

You must login to watch this lecture.

Error

You must login to watch this lecture.

51:06

Professor Sir Mark Walport, Director of the Wellcome Trust.

Archived View
28:42

Dr Daniel Gale, UCL & West London Renal and Transplant Centre.

CPD Archived View
51:48

Dr Carlo Croce, Comprehensive Cancer Center, USA.

CPD View
21:16

Jonathan O'Halloran & Elaine Warburton, QuantuMDx Group.

Free View
53:34

Sir John Burn, Professor of Clinical Genetics, Newcastle University.

Free View
22:12

Fiona Karet, Professor of Nephrology, University of Cambridge. 

CPD View
31:15

Lucy Raymond, Reader in Neurogenetics, University of Cambridge.

CPD View
57:20
Free View
45:43

Elizabeth Blackburn, Biological Researcher, The University of California.

Free View

Error

You must login to watch this lecture.